Focus Taiwan App

Moderna establishes Taiwan unit to enhance cooperation

09/30/2022 12:53 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

United States biotechnology company Moderna Inc., one of the two leading makers of mRNA vaccines for COVID-19, officially established a subsidiary in Taiwan on Thursday to expand its presence in the market, according to a company statement.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.